Development of a Composite Score for the Clinical Assessment of Anti-IgLON5 Disease.
Carles GaigThomas GrüterAnna HeidbrederLidia SabaterAlex IranzoJoan Santamaria CanoChristian SchmidtJosep O DalmauIlya AyzenbergFrancesc GrausPublished in: Neurology (2024)
The ICS is a valid method to assess the extension and severity of the different clinical manifestations of anti-IgLON5 disease.
Keyphrases